KRAS-IN-43
KRAS-IN-43 (Compound 9) is a pan-KRAS inhibitor with IC50 values of 0.15 μM, 0.14 μM, and 0.47 μM against KRASG12V, KRASG12C and wild-type KRAS, respectively. KRAS-IN-43 disrupts the interaction between KRAS and cRAF, and inhibits ERK phosphorylation. KRAS-IN-43 is promising for research of KRAS mutation-related cancers (such as pancreatic cancer, colorectal cancer, and lung cancer).
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Formule: C30H29FN2O3
- Masse moléculaire:484.56
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Pureté et documentation
- Références
-
Help & FAQs
Activité biologique
|
KRas G12V 0.15 μM (IC50) |
KRas G12C 0.14 μM (IC50) |
K-Ras WT 0.47 μM (IC50) |
Chemical Information
-
Masse moléculaire 484.56
-
Formule C30H29FN2O3
-
SMILES
C#CC1=C(C=CC2=CC(O)=CC(C(N3CCC4=C(C3)C=CC=C4OCC56CCCN5CCC6)=O)=C21)F
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
KRAS-IN-43 Related Classifications
HY-176250 Related Classifications
Powered by Bioz